Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-10 09:30 am Sale | 2023-03-09 | 13G | Erasca, Inc. ERAS | FMR LLC | 1,078,970 0.783% | -8,358,274 (-88.57%) | Filing History |
| 2023-02-14 4:20 pm Sale | 2022-12-31 | 13G | Erasca, Inc. ERAS | City Hill LLC | 30,293,326 24.700% | -1,762,256 (-5.50%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Erasca, Inc. ERAS | PFM Health Sciences LP | 4,797,460 3.200% | -2,953,028 (-38.10%) | Filing History |
| 2023-02-09 10:59 am Sale | 2023-02-09 | 13G | Erasca, Inc. ERAS | FMR LLC | 9,437,244 6.853% | -3,584,706 (-27.53%) | Filing History |
| 2022-12-21 4:32 pm Purchase | 2022-12-13 | 13D | Erasca, Inc. ERAS | Cormorant Asset Management, LP | 10,893,107 7.260% | 387,554 (+3.69%) | Filing History |
| 2022-12-19 4:21 pm Purchase | 2022-12-09 | 13G | Erasca, Inc. ERAS | Novartis Pharma AG | 12,307,692 8.200% | 12,307,692 (New Position) | Filing History |
| 2022-09-06 4:02 pm Purchase | 2022-08-26 | 13G | Erasca, Inc. ERAS | PFM Health Sciences LP | 7,750,488 6.300% | 7,750,488 (New Position) | Filing History |
| 2022-03-18 5:01 pm Purchase | 2021-12-31 | 13G | Erasca, Inc. ERAS | Colt Ventures Ltd. | 6,488,040 5.351% | 6,488,040 (New Position) | Filing History |
| 2022-02-11 6:04 pm Purchase | 2021-12-31 | 13G | Erasca, Inc. ERAS | City Hill LLC | 32,055,582 26.400% | 32,055,582 (New Position) | Filing History |
| 2022-02-10 5:04 pm Purchase | 2021-12-31 | 13G | Erasca, Inc. ERAS | ARCH Venture Fund X L.P. | 11,055,554 9.100% | 11,055,554 (New Position) | Filing History |
| 2022-01-10 1:26 pm Purchase | 2022-01-07 | 13G | Erasca, Inc. ERAS | FMR LLC | 13,021,950 10.739% | 13,021,950 (New Position) | Filing History |
| 2021-08-10 4:01 pm Unchanged | 2021-07-26 | 13D | Erasca, Inc. ERAS | Cormorant Asset Management, LP | 10,505,553 8.830% | 0 (Unchanged) | Filing History |
| 2021-07-30 4:01 pm Purchase | 2021-07-20 | 13D | Erasca, Inc. ERAS | Cormorant Asset Management, LP | 10,505,553 8.830% | 10,505,553 (New Position) | Filing History |